Unlock stock picks and a broker-level newsfeed that powers Wall Street.
27.40
-1.90
(-6.48%)
At close: April 1 at 4:00:01 PM EDT
26.70
-0.70
(-2.55%)
Pre-Market: 4:56:17 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | -1.76 | -1.85 | -7.19 | -5.8 |
| Low Estimate | -1.93 | -1.97 | -7.81 | -6.45 |
| High Estimate | -1.47 | -1.7 | -6.49 | -4.9 |
| Year Ago EPS | -1.45 | -1.69 | -6.02 | -7.19 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 9 | 9 |
| Avg. Estimate | 9.86M | 10.42M | 51.19M | 163.73M |
| Low Estimate | 9.04M | 9.8M | 42M | 111M |
| High Estimate | 10.4M | 11.8M | 78.31M | 210.2M |
| Year Ago Sales | 8.19M | 8.62M | 36.5M | 51.19M |
| Sales Growth (year/est) | 20.36% | 20.99% | 40.24% | 219.87% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.68 | -1.61 | 7.91 | -1.63 |
| EPS Actual | -1.45 | -1.69 | -1.47 | -1.74 |
| Difference | 0.24 | -0.08 | -9.38 | -0.11 |
| Surprise % | 13.95% | -4.86% | -118.52% | -6.75% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.76 | -1.85 | -7.19 | -5.8 |
| 7 Days Ago | -1.76 | -1.85 | -7.19 | -5.8 |
| 30 Days Ago | -1.7 | -1.74 | -5.8 | -5.16 |
| 60 Days Ago | -1.7 | -1.74 | -5.69 | -5.15 |
| 90 Days Ago | -1.7 | -1.74 | -5.51 | -5.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 2 | 1 |
| Down Last 30 Days | -- | -- | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AGIO | -21.38% | -9.66% | -19.50% | 19.37% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/24/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 12/18/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 12/10/2024 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 12/9/2024 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 11/1/2024 |
| Initiated | Scotiabank: Sector Outperform | 10/16/2024 |
Related Tickers
RARE Ultragenyx Pharmaceutical Inc.
33.84
-6.55%
IRON Disc Medicine, Inc.
47.15
-5.02%
PTCT PTC Therapeutics, Inc.
46.60
-8.56%
BPMC Blueprint Medicines Corporation
85.94
-2.90%
KYMR Kymera Therapeutics, Inc.
25.24
-7.80%
VERA Vera Therapeutics, Inc.
22.02
-8.33%
DYN Dyne Therapeutics, Inc.
9.23
-11.76%
PTGX Protagonist Therapeutics, Inc.
46.88
-3.06%
IONS Ionis Pharmaceuticals, Inc.
27.26
-9.65%
INCY Incyte Corporation
60.91
+0.59%